Burning Rock Biotech (BNR) Cash & Current Investments: 2020-2025
Historic Cash & Current Investments for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $65.6 million.
- Burning Rock Biotech's Cash & Current Investments fell 25.21% to $65.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.6 million, marking a year-over-year decrease of 25.21%. This contributed to the annual value of $71.5 million for FY2024, which is 17.44% down from last year.
- Per Burning Rock Biotech's latest filing, its Cash & Current Investments stood at $65.6 million for Q3 2025, which was up 3.27% from $63.5 million recorded in Q2 2025.
- Over the past 5 years, Burning Rock Biotech's Cash & Current Investments peaked at $331.9 million during Q2 2021, and registered a low of $63.5 million during Q2 2025.
- Its 3-year average for Cash & Current Investments is $85.6 million, with a median of $85.2 million in 2024.
- In the last 5 years, Burning Rock Biotech's Cash & Current Investments skyrocketed by 14,286.94% in 2021 and then tumbled by 48.56% in 2023.
- MRQ analysis of 5 years shows Burning Rock Biotech's Cash & Current Investments stood at $234.6 million in 2021, then plummeted by 42.82% to $134.2 million in 2022, then crashed by 35.41% to $86.7 million in 2023, then decreased by 17.44% to $71.5 million in 2024, then decreased by 8.30% to $65.6 million in 2025.
- Its Cash & Current Investments stands at $65.6 million for Q3 2025, versus $63.5 million for Q2 2025 and $68.5 million for Q1 2025.